The Japanese Society of Hypertension (JSH) revised the Guidelines for the Management of
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …

Obstructive sleep apnoea (OSA) is frequently associated with comorbidities that include
metabolic, cardiovascular, renal, pulmonary and neuropsychiatric. There is considerable …

Sleep apnea occurs in 5% to 10% of the general population, regardless of race and
ethnicity. 1 By contrast, in patients with cardiovascular diseases (CVDs), its prevalence …

Obstructive sleep apnoea (OSA) is common in the general population and increases the risk
of motor vehicle accidents due to hypersomnolence from sleep disruption, and risk of …

Background—Obstructive sleep apnea (OSA) and central sleep apnea are common in
patients with heart failure. We hypothesized that in such patients, severity of OSA is related …

Ambulatory BP studies indicate that even small increases in BP, particularly nighttime BP
levels, are associated with significant increases in cardiovascular morbidity and mortality …

Rationale: The cause of increased pharyngeal collapsibility in patients with obstructive sleep
apnea is incompletely understood. In awake healthy subjects, we showed that fluid …

Obstructive sleep apnea (OSA) exposes the cardiovascular system to intermittent hypoxia,
oxidative stress, systemic inflammation, exaggerated negative intrathoracic pressure …

Obstructive sleep apnoea (OSA) and hyperaldosteronism are very common in subjects with
resistant hypertension. We hypothesized that aldosterone-mediated chronic fluid retention …

There is a bidirectional association between OSA and systemic hypertension. The strengths
of this relationship appear to be modulated by factors such as age, sex, and somnolence …